Otros idiomas Coloplast A/S

Acciones

COLO B

DK0060448595

Equipo médico, suministros y distribución

Mercado cerrado - Nasdaq Copenhagen Otros sitios de cotización 17:20:00 04/12/2025			Variación 5 días	Varia. 1 de enero.
585,20 ^DKK	+1,14 %		+0,17 %	-25,57 %

04/12	Coloplast A/S Anuncia Cambios en su Consejo de Administración	CI
04/12	Coloplast A/S Declara Dividendo de Fin de Año para 2025	CI

Otros idiomas

Coloplast A/S Announces Directorate Changes	04/12
Coloplast A/S Approves Year End Dividend for the Financial Year 2024/25	04/12
Coloplast A/S Approves Interim Dividend for the Year 2025	04/12
Coloplast A/S : Presentation (agm uk ppt presentation)	04/12
Coloplast A/S : Decisions of AGM (coloplast a s announcement decisions of the agm)	04/12
Coloplast A/S - Decisions at the Annual General Meeting 2025	04/12
Coloplast A/S : Renumeration Policy (remuneration policy draft for 2025 annual general meeting)	11/11
Coloplast A/S : Notice of Annual General Meeting (notice convening annual general meeting 2025)	11/11
Coloplast A/S - Notice of Annual General Meeting 2025	11/11
Coloplast A/S : FY 2024/25 Transcript (313 kb) (corrected transcript coloplast a scolo.b dk q4 2025 earnings call 4 november 2025 5 00 am et)	05/11
Coloplast outperforms on profit in Q4 2025 as CEO transition and China risks shape 2026 outlook	04/11
Coloplast A/S : FY 2024/25 Presentation (485 kb) (fy 2024 25 conference call presentation 1)	04/11
Coloplast A/S Provides Earnings Guidance for the Fiscal Year 2025-2026	04/11
Coloplast A/S : ESG (11 2025 annual report 2024 25)	04/11
Coloplast A/S Recommends Year-End Dividend	04/11
Coloplast A/S Reports Earnings Results for the Fourth Quarter Ended September 30, 2025	04/11
Coloplast A/S : Remuneration Report (11 2025 remuneration report 2024 25)	04/11
Coloplast A/S : Annual report for 2024/25 (11 2025 annual report 2024 25)	04/11
Europe's STOXX 600 hits two-week lows on global risk-off mood, mixed earnings	04/11
Coloplast A/S Reports Earnings Results for the Fourth Quarter and Full Year Ended September 30, 2025	04/11
Bourse : Palantir déçoit, bioMérieux avertit, Edenred dévoile ses ambitions et Nintendo voit plus haut	04/11
Coloplast A/S : Interim Financial Report (10 2025 fy 2024 25 earnings release)	04/11
Coloplast Logs Lower FY25 Net Profit; Revenue Rises	04/11
Coloplast A/S : Conference Call Presentation (fy 2024 25 conference call presentation)	04/11
Coloplast A/S : Roadshow Presentation (fy 2024 25 roadshow presentation)	04/11

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripciones Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Acciones

COLOPLAST : Beneficio supera expectativas en el cuarto trimestre de 2025 en medio de transición de liderazgo

04 de noviembre 2025 a las 18:26